Wael Alanazi earned his Bachelor’s degree in Pharmaceutical Sciences from King Saud University in 2011. After graduation, Wael worked for the Drug Sector at Saudi Food and Drug Authority (SFDA) for evaluation of the quality of pharmaceutical products. In 2012, he worked as a teaching assistant in Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University. In 2013, Wael started his doctoral research in Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, USA. He joined Dr. Jackson’s laboratory and completed his thesis titled “The role of recurrent insulin-induced hypoglycemia on renal prostanoids production, (pro)renin receptor expression, and oxidative stress in heart and kidney”. In 2016, Wael earned his Ph.D. in Pharmacology and published several peer-reviewed articles. In 2017, Dr. Wael joined the Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, as an assistant professor, and was promoted to associate professor in 2021.
Education
- Bachelor's degree in Pharmaceutical Sciences, King Saud University (2011-2011)
- Ph.D. in Pharmacology, University of Louisiana at Monroe (2013-2016)
Research Interests
Keywords:
Diabetes-induced renal and cardiovascular diseases Renin angiotensin system Cyclooxygenases Oxidative stress Diabetic complications Antidiabetic activities
Professional Links